INTRODUCTION
Chronic kidney disease (CKD) is increasing in incidence, as is cardiovascular disease. Both carry large risks of major morbidity and mortality. The interaction of these two conditions is complex and the addition of CKD to cardiovascular disease worsens the long term prognosis in the latter [1] . Percutaneous intervention (PCI) for obstructive CAD is technically feasible in CKD patients. But PCI did not ameliorate the increased morbidity and mortality associated with CKD and certain procedural complications like access site complications, major bleeding and contrast nephropathy were actually increased in these patients compared to non-CKD patients [2, 3] . Vascular and bleeding complications are known to occur after PCI. These range from pseudo-aneurysm, arterial occlusion, local access site bleed, GI bleed, intraocular, intracranial and retroperitoneal bleed. In this study we tried to analyze the influence of CKD on the occurrence of post-PCI vascular and bleeding complications.
MATERIALS AND METHODS:
STUDY POPULATION: We retrospectively analyzed the obstructive CAD patients who underwent PCI in our institution which is a high volume center between January to august 2013. The patients who underwent PCI both elective and emergency were included in this study. Patients who needed intra-aortic balloon counter pulsation and larger coronary devices like atherectomy device or rotablator were excluded from the study. DATA COLLECTION: Demographic and clinical data on age, gender, smoking habit, diabetes mellitus (DM), and hypertension were obtained via review of patient medical case sheets. Body mass index (BMI) was measured by weight and height of patient and expressed as kg/m2. All blood examinations including total cholesterol, triglycerides, high density lipoprotein (HDL) cholesterol, low density lipoprotein (LDL) cholesterol, fasting blood glucose (FBG), creatinine, hemoglobin were measured after an overnight fast of at least 12 hr. Serum creatinine was measured by enzymatic method. All the patients underwent PCI with uniform sheath size of 6 F. All the patients enrolled in the study were given 325 mg aspirin and clopidogrel 600 mg or prasugrel 60 mg loading dose independent of their previous antiplatelet intake status to attain therapeutic drug levels and blood sample for platelet inhibition was collected 2 hours later. Anticoagulation is done with weight adjusted standard dose unfractionated heparin (100 units/kg body weight) bolus. Sheath removal and compression was done manually in all patients by trained cath-lab personnel. DEFINITIONS: CKD was defined as baseline GFR<60/mL/min as calculated by the Cockcroft-Gault formula: (140-age)×(weight) (×0.85 if female)/(72×serum creatinine).
This formula has been validated and accurately predicts the glomerular filtration rate [4] . Vascular complications: Only the outcomes that occurred in hospital were included in the analyses. They include one or more of the following: access site (hematoma, pseudo-aneurysm), non-access site (retroperitoneal, genitourinary, gastrointestinal, intracranial) hemorrhage. Bleeding Academic Research Consortium Definition for bleeding [5] was adopted in our study. Large local hematoma is defined as >10 cm size of blood collection with femoral access, >2 cm with radial access, or >5 cm with brachial access. Pseudoaneurysm is defined as the occurrence of a disruption and dilation of the arterial wall without identification of the arterial wall layers at the site of the catheter entry demonstrated by arteriography or ultrasound. STATISTICAL ANALYSIS: Baseline characteristics were compared between patients with CKD to patients without CKD. Continuous variables were expressed as the mean ± standard deviation (SD) and compared using an unpaired two-sided Student's t-test when normal distribution and equal dispersion were confirmed. Categorical variables were expressed as percentages (%) and compared using chi-square analysis . A multiple logistic regression analysis was performed to correlate eGFR with other variables (age ,weight ,height, hemoglobin, platelet count). A p-value of less than 0.05 was considered statistically significant. All statistical analyses were performed with MINITAB (version 17.0 for Windows).
RESULTS:
950 eligible patients who underwent PCI procedures were included in the study. M:F::3.4:1 with age ranging between 18 to 89 yrs. Out of 950 total patients,215 were females with mean age of 55.4+_10.5years. Demographic details were given in Table 1 There was small correlation of eGFR & age (r = 0.13,p = 0.00) and hemoglobin (r = 0.14,p = 0.00). 3D scatter plot of eGFR vs age vs height (Fig 2) and surface plot of eGFR vs age, hemoglobin (Fig 3) of the study population shows that older age group is associated with decrease eGFR. This study population of 950 patients were classified into CKD group (n = 380, 40%) and non-CKD groups (n = 570, 60%).Baseline demographic and clinical characteristics are given in the Table 2 and Fig 4. CKD patients were slightly older, less BMI, anemic than Non-CKD patients. As the all patients were taken up with prior treatment there was no difference in total cholesterol and systolic BP. Table 3 is showing the details of PCI. Total number of lesions in CKD and non CKD groups: Total no of lesions treated in 950 patients were 1243.
Multi-vessel angioplasty and radial route were done more frequently in non-CKD compared with CKD patients with a significant p value as shown in Table 4 and 667)] and the result was found to be statistically significant. Further analysis of vascular complications with chi-square when evaluated as access site (hematoma and pseudo aneurysm at access site) vs nonaccess site (retroperitoneal and other site bleeds) complication, CKD was associated with non-access site complications (p=0.01) , but not for access site complication (p= 0.06) as shown in Table 5 . But in our study in basal status itself there was difference in presence of DM, single or multi vessel PCI, route of PCI in cases of CKD vs NON-CKD, which is a limitation in the interpretation of this nominal regression analysis. After removal of variables which had already statistical difference, then after running nominal regression for occurrence of different types of vascular complications, hypertension , basal hemoglobin and eGFR were found to be dependent factors.
DISCUSSION:
Previous studies have found a strong association between impaired kidney function and bleeding complications following PCI [6, 7] . Several mechanisms can explain this observation. Patients with CKD have uremia which itself causes platelet and endothelial dysfunction. Platelet count is usually within the normal range or slightly low in patients with uremia. It has been suggested that these patients have a complex platelet dysfunction and an abnormal platelet-endothelial vessel wall interaction. Radioligand studies have indicated that the binding of fibrinogen to ADP-stimulated platelets in uremic media is impaired. Notably, the ability of the vessel wall to generate the potent anti-aggregatory substance prostacyclin (prostaglandin I2) increases in uremia; moreover, endothelial cells seem to generate an abnormal complex of coagulation factor VIII (antihemophilic factor) and Von Willebrand factor (vWF). Finally, the largest polymers of vWF, which are primarily responsible for the adhesion process, are deficient in patients with uremia, although the serum level of vWF in these patients is usually high or within the normal range. TRA was associated with reduced access site complications [8] . In our study lesser number of CKD patients underwent PCI through TRA compared with femoral access . Though vascular complications were higher in CKD group, these were mainly non-access site bleeds, suggesting femoral route is not predisposing factors for vascular complications in CKD patients. Retroperitoneal bleed is considered as complication of femoral access site, but in our series we have seen this complication even in radial routes. So, all retro-pertonial bleeds may not be due to access site complication. CKD patients have platelet and endothelial dysfunction which could have probably led to this observation. Reduced access site complications in spite of increased femoral access site PCI in CKD group could have been due to the reason that ours being a high volume center which may have a direct bearing on the procedural outcome. Patients in CKD group are aged compared to non-CKD group .Increased vascular complications are known to occur in elderly [9, 10] . age has been identified as an independent risk factor for bleeding in patients undergoing PCI [11] . The higher incidence of bleeding and other procedural outcomes after PCI in the elderly may be due to the higher incidence of comorbidities, including more extensive atherosclerosis, hypertension and renal insufficiency, as well as their more frequent presentation with hemodynamic instability or shock and the more frequent usage of femoral arterial access [12] Aged Multivessel PCI is associated with increased procedural time, fluoroscopy time ,use of larger size catheter and increased contrast dose. In our study larger number of non CKD patients underwent multivessel angioplasty but complication rate was less in this group compared to CKD group. STUDY LIMITATIONS: There were few differences in baseline characteristics like age, BMI, diabetes, hemoglobin levels between the two study groups because the study design was retrospective and this might have contributed to the observations noted. CKD staging could have thrown light into the stage specific risks associated in CKD patients. Procedural and fluoroscopy time was not routinely noted which might vary in multivessel PCI. The basal difference noted in our study in the presence of DM, single or multi vessel PCI, route of PCI was a limitation in the interpretation of nominal regression analysis. CONCLUSIONS: Our study highlights the importance of identifying CKD patients during PCI as they are found to be at a higher risk of post PCI vascular complications. The mechanisms behind this are multifactorial. Future studies should continue to evaluate this risk as common risk factors determine both CKD and vascular disease.
